News

Interview with HITLAB on Medical Data Infrastructure, Automation and AI

In this video interview with HITLAB at Columbia University in New York, Hexoskin's CEO Pierre-Alexandre Fournier discusses how fundamental building medical data infrastructure was to enable automation and AI - tools to make healthcare delivery more efficient and more accessible.

The lack of electronic medical records and data standards has slowed progress in digital health and AI in the 2000s and 2010s. Today the infrastructure is ready to make data collected by patients actionable and valuable.

This new IT environment (EHR/EMRs, broadband, FIRH, HL7, smart phones, and wearables) accelerates automation and AI development, digital biomarker discovery, personalized medicine and new health prevention services.

Hexoskin is building on this infrastructure to offer high-resolution vital signs monitoring with Hexoskin and Astroskin wearables, apps to collect patient reported outcomes and events, could storage, data automation and cohort management.

Please reach out to see how Hexoskin can help.

Conversation with Dr. Martin Gershon of Endeavor Venture Fund

Dr. Martin Gershon, Managing Partner/CIO of Endeavor Venture Fund and physician entrepreneur, had a 30 minutes conversation today with Hexoskin's CEO Pierre-Alexandre Fournier.

They talked about the journey of Hexoskin and the new landscape for medical wearables, connected sensors, digital biomarkers, the future of diagnostics and clinical research. They also emphasized the importance of collaboration and community to build innovative solutions that benefit patients, caregivers, and providers.

The live webinar recording is available below.

Hexoskin's Co-Founder and CEO Pierre-Alexandre Fournier on The Bleeding Edge of Digital Health Podcast

In this episode of the Bleeding Edge of Digital Health, host Mike Moore speaks with entrepreneur, scientist, and co-founder of Hexoskin, Pierre-Alexander Fournier.

Mike and Pierre talk about how his latest tech garment is being utilized in health care today, how it is benefiting not just the patient but the physician as well, and more importantly, the future products and garments in Hexoskin’s pipeline that will pave the way for further innovation and change the way we take care of our health, and the health of the ones we care about. Be sure to listen to the entire session.

Notable Quotes

“So, we're working on different garments. We do have another product that has more sensors called the Astroskin that is being used in research, and that's the product that is being used in the space station right now for different research projects in microgravity. The Astroskin is the model Chris Hemsworth is wearing in Limitless.”

“Research groups we're working with have built the largest database of vital signs for many specific health conditions. So, there are a lot of things that will come out of it. And as I said earlier, we're not just building a product for single use. Eventually, we're going to add blocks to that platform so that it can be used for several types of disease, and it's going to become a great bundle for people with comorbidities.”

Podcast links:

Apple Podcast

Spotify

Google Podcasts

Youtube (full video)

CGI and Hexoskin to Work Together on Connected Medical Clinic Project

The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.

Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.

Hexoskin will contribute Astroskin devices and AI-based medical software to the project. A first demonstration is planned for June 2023.

About the Connected Care Medical Modules

Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.

One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.

(photo: Canadian Space Agency)

Hexoskin Talks Space Medicine at the Healthcare without Boundaries Colloquium

Biomedical researcher Héloïse Auger will talk about Hexoskin's work in space medicine, Astroskin wearable sensors, and artificial intelligence for automated diagnostics at the Healthcare without Boundaries Colloquium this week on June 1-2. Registration is available on Eventbrite: Healthcare without Boundaries Colloquium

Hexoskin has been collaborating with the Canadian Space Agency since 2011 on the development of medical technologies that can be used for human spaceflight. Devices that can record health data passively, like the Astroskin, create an opportunity to develop autonomous medical systems using clinical rules and artificial intelligence to support long-term space missions beyond low Earth orbit.

Hexoskin takes part in the AAIH reflection about Artificial Intelligence in Healthcare

The Alliance for Artificial Intelligence in Healthcare (AAIH) just published a white paper titled "A Primer on AI in Healthcare".

The Primer on AI in Healthcare attempts to cover many uses for AI in healthcare in a way that is accessible, but also as precise and concrete as possible. We hope this document will serve as a reference for future discussions and publications for all stakeholders in healthcare and AI, including patients and providers.

A Primer on Artificial Intelligence in Healthcare - A technical introduction
The 45-page document describes AI approaches and applications in healthcare and biopharma research, and helps introduce standard definitions for the industry.

The Hexoskin Team is proud to have taken part in this reflection that will drive the future of AI development for Connected Health in healthcare.

"It was important for me to contribute to this essential white paper. There was a need to clarify terms and concepts in AI with an emphasis on applications in healthcare, biomedical discovery, clinical development, and home care". Pierre-Alexandre-Fournier - CEO at Hexoskin.

Hexoskin presents its data-driven model for algorithms development and AI services at Intelligent Health 2019, in Basel

On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.

Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.

Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.

The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.

Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.

“Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare”.

• Jean-François Roy is CTO and co-founder of Hexoskin (Carré Technologies Inc.). Since 2006 he leads the R&D company development to develop wearable biosensors and mobile applications.  He is a specialist in embedded systems, an experienced ASIC, FPGA and board designer. He also developed signal processing algorithms in many programming languages. He’s been involved with the design, development, integration, and testing of the Hexoskin/Astroskin system and related biomedical technologies since 2006.

 About Hexoskin:

Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.

The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.

Live Webinar - Join Us for the upcoming Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin

Join Us for our Hexoskin Live Webinar on February 27th! 

We invite you to attend our Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects.

HEXOSKIN LIVE WEBINAR:
Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speakers: 
Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker: 
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!

Hexoskin - AI Applications Summit Biopharma Boston

Our team will attend the AI Applications Summit Biopharma in Boston this week (October 25-26).

Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare. Over the years, we've worked with many organisations to develop systems to make a better use of clinical data, and we've learned a few things from it:

• Great AI needs great data: data collection is the foundation of all AI work.
• 90% of AI work is in processing and annotating data. AI modeling is the "easy" part.
• Define valuable endpoints first, then define how to collect the relevant data to build your models.
• When using connected devices and mobile devices for data collection, design a patient-centric pilot trial first to validate human factor assumptions.

There's a lot more to know to operationalize AI projects in clinical trials of course. Even when working with a technological partner, you'll need to have people in your team with the skills to manage the digital component of the project. Please reach out to us if you need advice on best practices and operations.

In short, there's a lot of opportunity for AI in clinical trials, from patient recrutement to data modeling, including virtual trials and phase IV trials. We're looking forward to share insights with you in Boston this week!

---

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.

Using Wearables, Data, and AI in Clinical Trials

Montréal InVivo hosted an event today in Laval, Québec, to discuss the use of data and AI in clinical trials. Representatives from Alta Sciences, a CRO focused on phase I/II trials in Canada and the US, and Accreon (Health IT), joined Hexoskin to discuss strategies and best practices.

On the picture below you can see Marc Paquin, Director of Partnerships and Business Development, sharing Hexoskin's experience with wearable sensors & AI software development for clinical trials.

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.